Daily Cosmetic Research Analysis
Across three randomized trials, chlorhexidine gluconate soaking markedly reduced intraoperative bacterial contamination in lumbar fusion, a combined oral care regimen outperformed standard toothbrushing for plaque and gingivitis, and a Zipline skin-closure device shortened closure time without worsening infection or scar cosmesis. Collectively, these studies support pragmatic procedural choices that can improve efficiency, hygiene outcomes, and perioperative infection control.
Summary
Across three randomized trials, chlorhexidine gluconate soaking markedly reduced intraoperative bacterial contamination in lumbar fusion, a combined oral care regimen outperformed standard toothbrushing for plaque and gingivitis, and a Zipline skin-closure device shortened closure time without worsening infection or scar cosmesis. Collectively, these studies support pragmatic procedural choices that can improve efficiency, hygiene outcomes, and perioperative infection control.
Research Themes
- Intraoperative antisepsis optimization in spine surgery
- Integrated oral hygiene regimens for gingivitis control
- Device-driven efficiency in surgical skin closure with preserved cosmesis
Selected Articles
1. Does intraoperative antiseptic solution soaking reduce microbial contamination in spine surgery? A randomized controlled trial.
In a single-blinded RCT of 105 lumbar fusion patients, chlorhexidine gluconate soaking before closure most effectively reduced intraoperative bacterial contamination, particularly on implant surfaces, compared with povidone-iodine and saline. Despite lower contamination, SSI rates were similarly low across groups at 6 months without antiseptic-related complications.
Impact: This head-to-head randomized comparison provides actionable evidence favoring chlorhexidine soaking to minimize intraoperative contamination on implants, a key surrogate for SSI risk in spine surgery.
Clinical Implications: Consider adopting chlorhexidine gluconate soaking prior to closure in instrumented lumbar fusion to reduce bacterial residues on implant surfaces, while awaiting multicenter trials powered for SSI endpoints.
Key Findings
- Pre-irrigation culture positivity was high: 49.5% (superficial), 31.4% (deep), 32.4% (implant).
- Chlorhexidine significantly reduced implant-surface contamination versus saline and povidone-iodine (OR 0.06 vs both; p≈.01).
- Povidone-iodine reduced superficial contamination only; normal saline showed no significant reduction.
- SSI rates over 6 months were low and similar across groups; no antiseptic-related complications.
Methodological Strengths
- Randomized, single-blinded, head-to-head comparison of three antiseptics with pre/post cultures at multiple tissue depths and implant surfaces
- Use of both culture and 16S rRNA PCR with multiplicity adjustment (Bonferroni) and predefined outcomes
Limitations
- Single-center design and surrogate primary endpoint (contamination) rather than SSI
- Short, fixed 3-minute soak protocol may not generalize to other durations or concentrations
Future Directions: Conduct multicenter RCTs powered for SSI reduction, evaluate different CHG concentrations/soak durations, and assess cost-effectiveness and safety across spine and other implant surgeries.
BACKGROUND CONTEXT: Surgical site infections (SSIs) are a significant complication in spine surgery, particularly in instrumented procedures, leading to increased morbidity and healthcare costs. Despite standard preoperative disinfection protocols, bacterial contamination remains prevalent. Strategies such as intraoperative antiseptic irrigation have been explored to mitigate contamination, yet the comparative efficacy of different antiseptic solutions remains unclear. PURPOSE: This study aimed to evaluate the effectiveness of intraoperative antiseptic solution soaking with normal saline (NS), povidone-iodine (PVP-I), and chlorhexidine gluconate (CHG) in reducing bacterial contamination in lumbar instrumented fusion surgery. STUDY DESIGN/SETTING: A single-center, single-blinded, randomized controlled trial was conducted at a tertiary medical center in Taiwan. PATIENT SAMPLE: A total of 105 patients undergoing posterior lumbar interbody fusion surgery were enrolled and randomly assigned to three groups: NS (n=35), PVP-I (n=35), or CHG (n=35). Patients with prior lumbar procedures, known allergies to antiseptics, previous spinal infections, trauma, or tumors were excluded. OUTCOME MEASURES: The primary outcome was the reduction in bacterial contamination, assessed via intraoperative cultures from three sites-superficial tissues, deep tissues, and implant surfaces-before and after antiseptic irrigation. Secondary outcomes included the incidence of postoperative SSIs and clinical complications over a 6-month follow-up period. METHODS: Patients were randomized into three groups, each receiving a 3-minute soak with the assigned antiseptic solution before wound closure, followed by normal saline irrigation. Swab samples were collected pre- and postirrigation for bacterial culture and 16S rRNA PCR analysis. Statistical analysis was performed using logistic regression and Bonferroni correction for multiple comparisons. RESULTS: Among 105 patients, preirrigation bacterial culture positivity rates were 49.5% in superficial tissues, 31.4% in deep tissues, and 32.4% on implants. Postirrigation, NS showed no significant bacterial reduction, while PVP-I reduced superficial contamination (55.0%, p=.015) but no significant effect in deeper tissues and implants. CHG showed the greatest bacterial reduction, significantly outperforming NS (OR: 0.06, 95% CI: 0.01-0.54, p=.011) and PVP-I (OR: 0.06, 95% CI: 0.01-0.56, p=.012) on implant surfaces. Despite these differences in culture rate, SSI rates remained low and comparable among groups (p=.72), with no reported antiseptic-related complications. CONCLUSION: This study confirms that bacterial contamination remains high despite standard preoperative disinfection in lumbar fusion surgery. Among the tested antiseptic solutions, CHG demonstrated superior efficacy in reducing bacterial residues, particularly on implant surfaces. These findings support CHG as a promising antiseptic for intraoperative irrigation in spine surgery. Further multicenter studies are needed to validate its impact on reducing SSIs and improving long-term outcomes. LEVEL OF EVIDENCE: Level II.
2. ANTIPLAQUE AND ANTIGINGIVITIS EFFECTS OF A NOVEL ORAL CARE REGIMEN FEATURING STANNOUS FLUORIDE TOOTHPASTE, A UNIQUE TOOTHBRUSH, AND CETYLPYRIDINIUM CHLORIDE MOUTHWASH: A RANDOMIZED CLINICAL TRIAL.
A 12-week masked RCT found that a regimen combining stannous fluoride toothpaste, cetylpyridinium chloride mouthwash, and a rapid-foaming manual toothbrush significantly reduced plaque and gingivitis versus standard toothbrushing, with effects evident by week 1 and sustained through week 12.
Impact: Demonstrates the incremental benefit of an integrated antibacterial oral-care regimen over standard brushing, informing pragmatic recommendations for gingivitis management.
Clinical Implications: For patients with gingivitis or high plaque burden, adding cetylpyridinium chloride mouthwash and using stannous fluoride toothpaste with an effective manual toothbrush can yield rapid and sustained improvements.
Key Findings
- Significant plaque and gingivitis reductions versus control began at week 1 (P<.01) and persisted through week 12 (P<.001).
- At week 1, the antibacterial regimen achieved 15-fold greater plaque reduction compared to control (P<.001).
- By week 3, 100% of participants in the antibacterial regimen group had improved gingival index scores from baseline.
Methodological Strengths
- Masked, randomized, parallel-group design with clinically relevant endpoints over 12 weeks
- Comparative evaluation of an integrated regimen versus a representative standard brushing control
Limitations
- Single-center study; potential generalizability limitations
- Composite regimen compared to control lacking mouthwash, making it difficult to isolate individual component effects
Future Directions: Head-to-head RCTs isolating component contributions, longer-term adherence and safety data, and microbiome and caries outcomes would strengthen evidence.
BACKGROUND: Antibacterial ingredients for oral care products are typically measured through single product forms. This study assessed the overall health outcome of using multiple forms: a stabilized stannous fluoride toothpaste, an enhanced cetylpyridinium chloride mouthwash and a unique toothbrush to deliver antibacterial performance. METHODS: A 12-week, single-center, phase III, masked, 2-arm, parallel-group, randomized controlled trial was conducted to assess the reduction of established dental plaque and gingivitis with a novel antibacterial oral regimen comprised of 0.454% stannous fluoride toothpaste stabilized with nitrate and phosphates, 0.075% cetylpyridinium chloride and 0.28% zinc lactate mouthwash, and rapid foaming manual toothbrush compared to a nonantibacterial commercially available regimen of toothpaste containing 0.76% sodium monofluorophosphate, no mouthwash, and commercially available manual toothbrush to represent standard toothbrushing practices. RESULTS: Adherence to this novel oral care regimen provided significant reduction in plaque and gingivitis compared to the control starting at 1 week (P < .01) and continuing over 12 weeks (P < .001) across all plaque and gingival score indices. At week 1, participants in the Antibacterial Regimen Group showed 15 times more plaque reduction than control (P < .001). After 3 weeks of regimen adherence, 100% of Antibacterial Regimen participants had improved gingival index scores compared to baseline. CONCLUSIONS: Within the limitations of the study, the results showed statistically significantly reduced gingival inflammation and improved plaque control from 1 week continuing through 12 weeks of adherence to this novel oral care regimen compared to standard toothbrushing practices.
3. Use of a zipline skin closure device in gastroenterological surgery: a multicenter randomized controlled trial assessing wound infection incidence, operation time, and cosmesis.
In a multicenter RCT (n=76), a Zipline skin-closure device significantly shortened closure time versus subcuticular sutures, especially for incisions >55 mm, with no increase in wound infections or worse scar scores at 6 months. This supports Zipline as an efficiency-enhancing alternative without compromising cosmesis.
Impact: Provides randomized evidence that a non-suture closure system can improve operating room efficiency while maintaining wound safety and cosmetic outcomes in gastrointestinal surgery.
Clinical Implications: Surgeons may consider Zipline closure for longer incisions to reduce closure time without sacrificing wound healing or scar cosmesis; training and cost analyses should inform adoption.
Key Findings
- Zipline reduced skin-closure time vs subcuticular sutures (median 438 s vs 575 s; p=0.003).
- Benefit was greater for incisions >55 mm (399 s vs 605 s; p=0.001).
- No significant differences in wound infection (5.7% vs 2.4%; p=0.46) or 6-month SBSES scar scores (median 4.0 vs 4.0; p=0.82).
Methodological Strengths
- Multicenter randomized controlled design with trial registration (UMIN000048169)
- Objective time measures and blinded 6-month scar assessment using SBSES
Limitations
- Modest sample size (n=76) limits power to detect differences in infections or cosmetic scores
- Blinding of surgeons and patients likely not feasible, introducing potential performance bias
Future Directions: Larger, cost-effectiveness studies across varied GI procedures and patient risk profiles; evaluation of patient-reported outcomes and scar quality with validated scales.
Subcuticular sutures, which are effective and cosmetically advantageous in gastroenterological surgery, are time-consuming and heavily dependent on the surgeon's technical expertise. This study aims to evaluate whether Zipline skin closure could be an alternative to subcuticular sutures in gastroenterological surgery. A multicenter randomized controlled trial (UMIN000048169) was conducted on 76 patients who underwent elective gastroenterological surgery. The patients were randomized to either the Zipline group (N = 35) or the subcuticular suture group (N = 41). Primary outcomes included skin closure time and secondary outcomes included postoperative wound complications and cosmetic results, assessed 6 months post-surgery, using the Stony Book Scar Evaluation Scale (SBSES). The Zipline group demonstrated significantly shorter closure times than the suture group (median: 438 s [406-526] vs. 575 s [537-638]; p = 0.003). This difference was more pronounced for incisions > 55 mm (median:399 s [307-533] vs. 605 s [493-736]; p = 0.001). No significant differences were observed in wound infection rates (5.7% vs. 2.4%; p = 0.46) or SBSES scores (median: 4.0 [4.0-5.0] vs. 4.0 [3.0-5.0; p = 0.82) between the two groups. The Zipline device reduced the skin closure time in gastroenterological surgery significantly, particularly for large incisions, without compromising wound healing or cosmetic outcomes. These findings suggest that the Zipline system may be a viable alternative to traditional subcuticular sutures in gastroenterological procedures, potentially promoting operating room efficiency without compromising surgical quality or patient outcomes.